To view or add a comment, sign in Ventyx shares jumped about 90% after Phase 2 data showed its NLRP3 drug cut cardiovascular risk results that could draw interest from partner Sanofi
GLP-1 medications: Transforming health and spending habits GLP-1 medications: Transforming health and spending habits GLP-1 medications: Transforming health and spending habits Listen Appetite-suppressing medications like Ozempic, Wegovy, and Zepbound are reshaping more than waistlines theyre transforming personal budgets, food habits, and even the economy
Instead, it makes more sense to advertise smaller or split portions
What Are Safer Alternatives to Retatrutide
Once they reach their goals, Midi clinicians may taper patients down to a lower dose, and sometimes ease them off semaglutide entirely, depending on their individual needs